{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=NGS+testing&page=2", "query": { "intervention": "NGS testing", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=NGS+testing&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-05T09:47:43.412Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05536713", "title": "Understanding Patient Preference on Colorectal Cancer Screening Options", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Colorectal Cancer" ], "interventions": [ { "name": "Guardant SHIELD blood-based colorectal cancer screening test", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "45 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "45 Years to 75 Years" }, "enrollment_count": 297, "start_date": "2023-02-09", "completion_date": "2025-12-18", "has_results": false, "last_update_posted_date": "2026-02-06", "last_synced_at": "2026-09-05T09:47:43.412Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05536713" }, { "nct_id": "NCT03520933", "title": "Multi-center Study to Validate niPGT-A", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Aneuploidy", "Chromosome Abnormality", "Infertility" ], "interventions": [ { "name": "PGT-A", "type": "DIAGNOSTIC_TEST" }, { "name": "niPGT-A", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Igenomix", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "20 Years", "maximum_age": "44 Years", "sex": "FEMALE", "summary": "20 Years to 44 Years · Female only" }, "enrollment_count": 2586, "start_date": "2018-04-27", "completion_date": "2023-02-10", "has_results": false, "last_update_posted_date": "2023-05-24", "last_synced_at": "2026-09-05T09:47:43.412Z", "location_count": 3, "location_summary": "San Diego, California • Boston, Massachusetts • Arlington, Washington", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Arlington", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03520933" }, { "nct_id": "NCT05295277", "title": "Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Developmental Disability", "Intellectual Disability", "Autism Spectrum Disorder", "Congenital Anomaly", "Fragile X Syndrome", "Facioscapulohumeral Muscular Dystrophy 1" ], "interventions": [ { "name": "Standard of care genetic testing group", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Bionano Genomics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1000, "start_date": "2020-11-30", "completion_date": "2024-06-30", "has_results": false, "last_update_posted_date": "2023-08-07", "last_synced_at": "2026-09-05T09:47:43.412Z", "location_count": 8, "location_summary": "Atlanta, Georgia • Augusta, Georgia • Iowa City, Iowa + 5 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "New York", "state": "New York" }, { "city": "West Henrietta", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05295277" }, { "nct_id": "NCT05158621", "title": "A Screening Study Targeting Tumor-specific Antigens", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Metastatic Colorectal Cancer", "Stage II/III Colon Cancer" ], "interventions": [ { "name": "blood collection for research (next generation sequencing [NGS])", "type": "PROCEDURE" }, { "name": "blood collection for research (HLA typing)", "type": "PROCEDURE" }, { "name": "blood collection for research (circulating tumor DNA [ctDNA])", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Gritstone bio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 22, "start_date": "2021-12-14", "completion_date": "2022-08-15", "has_results": false, "last_update_posted_date": "2022-10-18", "last_synced_at": "2026-09-05T09:47:43.412Z", "location_count": 6, "location_summary": "Miami, Florida • Tamarac, Florida • East Brunswick, New Jersey + 3 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Tamarac", "state": "Florida" }, { "city": "East Brunswick", "state": "New Jersey" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05158621" }, { "nct_id": "NCT07392970", "title": "Motixafortide for MRD Sensitization in AML", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Myeloid Leukemia", "Measurable Residual Disease" ], "interventions": [ { "name": "Motixafortide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2026-07-23", "completion_date": "2030-02-02", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-09-05T09:47:43.412Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT07392970" }, { "nct_id": "NCT04422314", "title": "ImmuneSense Lyme Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lyme Disease" ], "interventions": [ { "name": "T-Detect Lyme", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Adaptive Biotechnologies", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "7 Years", "maximum_age": null, "sex": "ALL", "summary": "7 Years and older" }, "enrollment_count": 893, "start_date": "2020-07-09", "completion_date": "2021-10-30", "has_results": false, "last_update_posted_date": "2022-04-15", "last_synced_at": "2026-09-05T09:47:43.412Z", "location_count": 34, "location_summary": "Danbury, Connecticut • Macon, Georgia • Savannah, Georgia + 29 more", "locations": [ { "city": "Danbury", "state": "Connecticut" }, { "city": "Macon", "state": "Georgia" }, { "city": "Savannah", "state": "Georgia" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "Lewiston", "state": "Maine" } ], "official_url": "https://clinicaltrials.gov/study/NCT04422314" }, { "nct_id": "NCT04712877", "title": "Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "NSCLC" ], "interventions": [ { "name": "ctDNA, tumor NGS", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Lung Cancer Mutation Consortium", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1000, "start_date": "2022-06-15", "completion_date": "2026-06-15", "has_results": false, "last_update_posted_date": "2024-07-17", "last_synced_at": "2026-09-05T09:47:43.412Z", "location_count": 21, "location_summary": "Davis, California • Los Angeles, California • Orange, California + 13 more", "locations": [ { "city": "Davis", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04712877" }, { "nct_id": "NCT07458230", "title": "Efficacy of Integrating Next Generation Sequencing for Treatment of Surgical Site Infection After Fracture Fixation:", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Next Generation Sequencing (NGS)", "Surgical Site Infection (SSI)", "Fracture Fixation" ], "interventions": [ { "name": "NGS diagnostic findings", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "18 Years to 84 Years" }, "enrollment_count": 250, "start_date": "2026-10-01", "completion_date": "2028-10-01", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-09-05T09:47:43.412Z", "location_count": 18, "location_summary": "Tuscaloosa, Alabama • Los Angeles, California • San Francisco, California + 15 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Maywood", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT07458230" }, { "nct_id": "NCT03330444", "title": "Development of a Microbiome Non-invasive Diagnosis Tool", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Infertility of Uterine Origin" ], "interventions": [ { "name": "Endometrial biopsy and endometrial fluid collection", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Igenomix", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 452, "start_date": "2017-08-04", "completion_date": "2020-06-25", "has_results": false, "last_update_posted_date": "2020-10-09", "last_synced_at": "2026-09-05T09:47:43.412Z", "location_count": 4, "location_summary": "Norwalk, Connecticut • Margate, Florida • Chesterfield, Missouri + 1 more", "locations": [ { "city": "Norwalk", "state": "Connecticut" }, { "city": "Margate", "state": "Florida" }, { "city": "Chesterfield", "state": "Missouri" }, { "city": "Arlington", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03330444" }, { "nct_id": "NCT04028479", "title": "The Registry of Oncology Outcomes Associated With Testing and Treatment", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Adenocarcinoma", "Adenocystic Carcinoma", "Anal Cancer", "Appendix Cancer", "Brain Tumor", "Glioblastoma", "Astrocytoma", "Bile Duct Cancer", "Cholangiocarcinoma", "Bladder Cancer", "Bone Cancer", "Synovial Sarcoma", "Chondrosarcoma", "Liposarcoma", "Sarcoma, Kaposi", "Sarcoma,Soft Tissue", "Sarcoma", "Osteosarcoma", "CNS Cancer", "Brain Stem Neoplasms", "Breast Cancer", "Cervical Cancer", "Colorectal Cancer", "Rectal Cancer", "Colon Cancer", "Esophageal Cancer", "Esophagus Cancer", "Cancer of Colon", "Pancreatic Cancer", "Cancer of Pancreas", "Testis Cancer", "Testicular Cancer", "Ureter Cancer", "Renal Cell Carcinoma", "Kidney Cancer", "Gestational Trophoblastic Tumor", "Head and Neck Neoplasms", "Parotid Tumor", "Larynx Cancer", "Tongue Cancer", "Pharynx Cancer", "Salivary Gland Cancer", "Acute Myeloid Leukemia", "Chronic Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Multiple Myeloma", "Non Hodgkin Lymphoma", "Carcinoid Tumor", "Lung Cancer", "Neuroendocrine Tumors", "Mesothelioma", "Thyroid Cancer", "Parathyroid Neoplasms", "Adrenal Cancer", "Small Bowel Cancer", "Stomach Cancer", "Liver Cancer", "Hepatic Cancer", "Melanoma", "Skin Cancer", "Unknown Primary Tumors", "Uterine Cancer", "Fallopian Tube Cancer", "Ovarian Cancer", "Prostate Cancer", "Vaginal Cancer", "Penile Cancer", "Vulvar Cancer", "Waldenstrom Macroglobulinemia", "Cancer, Advanced", "Thymus Cancer", "Nasopharyngeal Carcinoma", "Multiple Endocrine Neoplasia", "Pheochromocytoma", "Small Cell Carcinoma", "Pulmonary Carcinoma" ], "interventions": [ { "name": "Biomarker Testing (L)", "type": "DIAGNOSTIC_TEST" }, { "name": "Systemic Treatment (T)", "type": "DRUG" }, { "name": "Patient Reported Outcomes (P)", "type": "OTHER" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "DRUG", "OTHER" ], "sponsor": "Taproot Health", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 167, "start_date": "2021-05-05", "completion_date": "2024-10-31", "has_results": false, "last_update_posted_date": "2024-12-18", "last_synced_at": "2026-09-05T09:47:43.412Z", "location_count": 2, "location_summary": "Idaho Falls, Idaho • Laredo, Texas", "locations": [ { "city": "Idaho Falls", "state": "Idaho" }, { "city": "Laredo", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04028479" } ] }